Preterm Cord Blood Contains a Higher Proportion of Immature Hematopoietic Progenitors Compared to Term Samples
Open Access
- 29 September 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (9) , e0138680
Abstract
Cord blood contains high number of hematopoietic cells that after birth disappear. In this paper we have studied the functional properties of the umbilical cord blood progenitor cells collected from term and preterm neonates to establish whether quantitative and/or qualitative differences exist between the two groups. Our results indicate that the percentage of total CD34+ cells was significantly higher in preterm infants compared to full term: 0.61% (range 0.15–4.8) vs 0.3% (0.032–2.23) p = 0.0001 and in neonates <32 weeks of gestational age (GA) compared to those ≥32 wks GA: 0.95% (range 0.18–4.8) and 0.36% (0.15–3.2) respectively p = 0.0025. The majority of CD34+ cells co-expressed CD71 antigen (p<0.05 preterm vs term) and grew in vitro large BFU-E, mostly in the second generation. The subpopulations CD34+CD38- and CD34+CD45- resulted more represented in preterm samples compared to term, conversely, Side Population (SP) did not show any difference between the two group. The absolute number of preterm colonies (CFCs/10microL) resulted higher compared to term (p = 0.004) and these progenitors were able to grow until the third generation maintaining an higher proportion of CD34+ cells (p = 0.0017). The number of colony also inversely correlated with the gestational age (Pearson r = -0.3001 p<0.0168). We found no differences in the isolation and expansion capacity of Endothelial Colony Forming Cells (ECFCs) from cord blood of term and preterm neonates: both groups grew in vitro large number of endothelial cells until the third generation and showed a transitional phenotype between mesenchymal stem cells and endothelial progenitors (CD73, CD31, CD34 and CD144)The presence, in the cord blood of preterm babies, of high number of immature hematopoietic progenitors and endothelial/mesenchymal stem cells with high proliferative potential makes this tissue an important source of cells for developing new cells therapies.Keywords
This publication has 39 references indexed in Scilit:
- Long-term repopulating hematopoietic stem cells and “side population” in human steady state peripheral bloodStem Cell Research, 2013
- Mechanisms that Regulate Stem Cell Aging and Life SpanCell Stem Cell, 2013
- Intra-Aortic Clusters Undergo Endothelial to Hematopoietic Phenotypic Transition during Early EmbryogenesisPLOS ONE, 2012
- Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord BloodJournal of Visualized Experiments, 2012
- Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros regionJournal of Experimental Medicine, 2011
- ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesisDevelopment, 2011
- Single-lineage transcriptome analysis reveals key regulatory pathways in primitive erythroid progenitors in the mouse embryoBlood, 2011
- Human Placenta Is a Potent Hematopoietic Niche Containing Hematopoietic Stem and Progenitor Cells throughout DevelopmentCell Stem Cell, 2009
- The Pluripotency-Associated GeneDppa4Is Dispensable for Embryonic Stem Cell Identity and Germ Cell Development but Essential for EmbryogenesisMolecular and Cellular Biology, 2009
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007